118 related articles for article (PubMed ID: 17869250)
1. Catalytic domain of MMP20 (Enamelysin) - the NMR structure of a new matrix metalloproteinase.
Arendt Y; Banci L; Bertini I; Cantini F; Cozzi R; Del Conte R; Gonnelli L
FEBS Lett; 2007 Oct; 581(24):4723-6. PubMed ID: 17869250
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the catalytic domain of human matrix metalloproteinase 10.
Bertini I; Calderone V; Fragai M; Luchinat C; Mangani S; Terni B
J Mol Biol; 2004 Feb; 336(3):707-16. PubMed ID: 15095982
[TBL] [Abstract][Full Text] [Related]
3. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
Nar H; Werle K; Bauer MM; Dollinger H; Jung B
J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of matrix metalloproteinase-20 (MMP20; enamelysin) genes in reptile and amphibian.
Shintani S; Kobata M; Kamakura N; Toyosawa S; Ooshima T
Gene; 2007 May; 392(1-2):89-97. PubMed ID: 17223283
[TBL] [Abstract][Full Text] [Related]
6. Novel solution structure of porcine beta-microseminoprotein.
Wang I; Lou YC; Wu KP; Wu SH; Chang WC; Chen C
J Mol Biol; 2005 Mar; 346(4):1071-82. PubMed ID: 15701518
[TBL] [Abstract][Full Text] [Related]
7. Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.
Cuniasse P; Devel L; Makaritis A; Beau F; Georgiadis D; Matziari M; Yiotakis A; Dive V
Biochimie; 2005; 87(3-4):393-402. PubMed ID: 15781327
[TBL] [Abstract][Full Text] [Related]
8. Solution structure and characterization of the DNA-binding activity of the B3BP-Smr domain.
Diercks T; AB E; Daniels MA; de Jong RN; Besseling R; Kaptein R; Folkers GE
J Mol Biol; 2008 Nov; 383(5):1156-70. PubMed ID: 18804481
[TBL] [Abstract][Full Text] [Related]
9. Evidence of reciprocal reorientation of the catalytic and hemopexin-like domains of full-length MMP-12.
Bertini I; Calderone V; Fragai M; Jaiswal R; Luchinat C; Melikian M; Mylonas E; Svergun DI
J Am Chem Soc; 2008 Jun; 130(22):7011-21. PubMed ID: 18465858
[TBL] [Abstract][Full Text] [Related]
10. Structure of the N-terminal domain of the circadian clock-associated histidine kinase SasA.
Vakonakis I; Klewer DA; Williams SB; Golden SS; LiWang AC
J Mol Biol; 2004 Sep; 342(1):9-17. PubMed ID: 15313603
[TBL] [Abstract][Full Text] [Related]
11. Structural features of the reprolysin atrolysin C and tissue inhibitors of metalloproteinases (TIMPs) interaction.
Pinto AF; Terra RM; Guimarães JA; Kashiwagi M; Nagase H; Serrano SM; Fox JW
Biochem Biophys Res Commun; 2006 Sep; 347(3):641-8. PubMed ID: 16842758
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of a conserved domain of antizyme: a protein regulator of polyamines.
Hoffman DW; Carroll D; Martinez N; Hackert ML
Biochemistry; 2005 Sep; 44(35):11777-85. PubMed ID: 16128579
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the catalytic domain of RICH protein from goldfish.
Kozlov G; Denisov AY; Pomerantseva E; Gravel M; Braun PE; Gehring K
FEBS J; 2007 Mar; 274(6):1600-9. PubMed ID: 17480208
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of human SH3BGRL protein: the first structure of the human SH3BGR family representing a novel class of thioredoxin fold proteins.
Yin L; Xiang Y; Zhu DY; Yan N; Huang RH; Zhang Y; Wang DC
Proteins; 2005 Oct; 61(1):213-6. PubMed ID: 16080146
[No Abstract] [Full Text] [Related]
15. The solution structure of pGolemi, a high affinity Mena EVH1 binding miniature protein, suggests explanations for paralog-specific binding to Ena/VASP homology (EVH) 1 domains.
Link NM; Hunke C; Mueller JW; Eichler J; Bayer P
Biol Chem; 2009; 390(5-6):417-26. PubMed ID: 19284291
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling study of CodX reveals importance of N-terminal and C-terminal domain in the CodWX complex structure of Bacillus subtilis.
Krishnamoorthy N; Gajendrarao P; Eom SH; Kwon YJ; Cheong GW; Lee KW
J Mol Graph Model; 2008 Aug; 27(1):1-12. PubMed ID: 18400533
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling of the DNA-binding domain of human Smad5: a molecular model for inhibitor design.
Hariharan R; Pillai MR
J Mol Graph Model; 2006 Jan; 24(4):271-7. PubMed ID: 16243555
[TBL] [Abstract][Full Text] [Related]
18. High-resolution structural analysis of a novel octaheme cytochrome c nitrite reductase from the haloalkaliphilic bacterium Thioalkalivibrio nitratireducens.
Polyakov KM; Boyko KM; Tikhonova TV; Slutsky A; Antipov AN; Zvyagilskaya RA; Popov AN; Bourenkov GP; Lamzin VS; Popov VO
J Mol Biol; 2009 Jun; 389(5):846-62. PubMed ID: 19393666
[TBL] [Abstract][Full Text] [Related]
19. Homology modeling of human transketolase: description of critical sites useful for drug design and study of the cofactor binding mode.
Obiol-Pardo C; Rubio-Martinez J
J Mol Graph Model; 2009 Feb; 27(6):723-34. PubMed ID: 19111488
[TBL] [Abstract][Full Text] [Related]
20. Insight into the structural determinants for selective inhibition of matrix metalloproteinases.
Pirard B
Drug Discov Today; 2007 Aug; 12(15-16):640-6. PubMed ID: 17706545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
